JTT-302

DRUG2 trials

Sponsors

Akros Pharma Inc.

Conditions

Dyslipidemia

Phase 2

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

CompletedNCT00748852

Akros Pharma Inc.Dyslipidemia

Start: 2007-01-31End: 2008-03-31Updated: 2013-02-04

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

CompletedNCT00749788

Akros Pharma Inc.Dyslipidemia

Start: 2006-12-31End: 2008-02-29Updated: 2013-02-04